Public Dashboard: Morningstar 4 Bargains (9/11/2020)
These undervalued wide-moat stocks earn low uncertainty ratings. -- Susan Dziubinski
08/02/2025 | ||||||||||||
Company | Symbol | Shares | Price | Value | % of Total | Growth | Proj P/E | Proj Yield | Fin Str | EPS Stab | Qlty | PAR |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Averages | $540.67 | 3.5% | 14.1 | 2.6% | 54% | 61 | 63.6 | 8.6% | ||||
Coca-Cola | KO | 1.96 | $68.86 | $134.86 | 24.9% | 4.6% | 22.4 | 3.0% | 82% | 100 | 93 | 9.1% |
Novartis | NVS | 1.11 | $115.30 | $128.28 | 23.7% | 5.5% | 17.7 | 3.1% | 76% | 61 | 86 | 10.0% |
Pfizer | PFE | 2.77 | $23.49 | $65.12 | 12.0% | 2.2% | 10.3 | 4.6% | 49% | 56 | 59 | 12.9% |
Roche Holdings* | RHHBY | 2.21 | $38.88 | $85.94 | 15.9% | 4.9% | 19.8 | 3.5% | 60% | 95 | 82 | 15.2% |
Vanguard Total Stock Market | VTSMX | 1.22 | $104.05 | $126.46 | 23.4% | 0.0% | 0.0 | 0.0% | 0% | 0 | 0 | -0.1% |